KYOWA KIRIN CO., LTD.
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）
- First Posted Date
- 2025-04-13
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT06926491
- Locations
- 🇯🇵
Aichi Children's Health and Medical Center, Ōbu, Aichi, Japan
🇯🇵Osaka University Hospital, Suita, Osaka, Japan
🇯🇵Osaka Women's and Children's Hospital, Waizumi, Osaka, Japan
Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
- Conditions
- Healthy Volunteers Essential Hypertension
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT06823947
- Locations
- 🇯🇵
Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan
Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Conditions
- Relapsed or Refractory Acute Myeloid Leukemia
- Interventions
- Drug: KK2845_2Drug: KK2845_1Drug: KK2845_3Drug: KK2845_4
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06812104
- Locations
- 🇯🇵
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06525636
- Locations
- 🇺🇸
Yale Center for XLH/ Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸University of California - San Francisco, San Francisco, California, United States
🇺🇸Indiana University School of Medicine University Hospital, Indianapolis, Indiana, United States
A Study of KK2269 in Adult Participants With Solid Tumors
- Conditions
- Metastatic Solid TumorEsophageal AdenocarcinomaAdvanced Solid TumorGastroesophageal Junction AdenocarcinomaNon Small Cell Lung CancerGastric Adenocarcinoma
- Interventions
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 71
- Registration Number
- NCT06266299
- Locations
- 🇺🇸
City Of Hope, Duarte, California, United States
🇺🇸Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇯🇵Aichi Cancer Center, Nagoya city, Aichi, Japan
A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 169
- Registration Number
- NCT06248411
- Locations
- 🇯🇵
Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
🇯🇵Kobe University Hospital, Kobe, Hyogo, Japan
🇯🇵Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka, Japan
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
- Conditions
- Neovascular Age-Related Macular Degeneration (nAMD)
- Interventions
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT06116890
- Locations
- 🇺🇸
Barnet Dulaney Perkins Eye Center - Phoenix, Mesa, Arizona, United States
🇺🇸Retina Associates Southwest, P.C., Tucson, Arizona, United States
🇺🇸Win Retina, Arcadia, California, United States
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
- Conditions
- Diabetic Macular Edema (DME)
- Interventions
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT06116916
- Locations
- 🇺🇸
Barnet Dulaney Perkins Eye Center - Phoenix, Mesa, Arizona, United States
🇺🇸Barnet Dulaney Perkins Eye Center - Phoenix, Mesa, Arizona, United States
🇺🇸Retina Associates Southwest, P.C., Tucson, Arizona, United States
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus
- Conditions
- Healthy VolunteersSystemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 116
- Registration Number
- NCT05411016
- Locations
- 🇯🇵
Fujita Health University Hospital, Kutsukake, Aichi, Japan
🇯🇵Japan Community Health care Organization Chukyo Hospital, Minami, Aichi, Japan
🇯🇵Juntendo University Urayasu Hospital, Urayasu, Chiba, Japan
Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO
- First Posted Date
- 2022-05-03
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT05357573
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
🇨🇳West China Hospital, Sichuan University, Chengdu, China
🇨🇳Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China